MedTrace Logo

Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI-MSLC)

NCT03795155 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-06-11

No results posted yet for this study

Summary

This prospective study is to characterize the genomic landscape and genetic heterogeneity of multiple synchronous lung cancer (MSLC) in correlation with comprehensive clinical, histopathological and medical imaging information, in order to improve disease diagnosis and tailored treatment for MSLC patients.

Conditions

  • Multiple Synchronous Lung Cancers (MSLCs)

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Xiaojing Zhao, M.D. · Ren Ji Hospital

  • Yujie Fu, Ph.D. · Ren Ji Hospital

  • Guanglei Zhuang, Ph.D. · Ren Ji Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2022-11-30
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03795155 on ClinicalTrials.gov